Colfax Corporation (CFX)
(Delayed Data from NYSE)
$30.27 USD
+0.52 (1.75%)
Updated May 3, 2019 04:02 PM ET
After-Market: $30.27 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$30.27 USD
+0.52 (1.75%)
Updated May 3, 2019 04:02 PM ET
After-Market: $30.27 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Factors Setting the Tone for Apogee's (APOG) Q3 Earnings
by Zacks Equity Research
Apogee's (APOG) Q3 performance likely to reflect benefits from solid bidding and order activities, robust backlog, and an upbeat North America commercial construction market.
Cintas (CTAS) to Report Q2 Earnings: Beat in the Cards?
by Zacks Equity Research
Cintas' (CTAS) fiscal second-quarter earnings are likely to have gained from strong prospects in Uniform Rental and Facility Services and First Aid and Safety Services segments.
Colfax (CFX) Shares Up 57.7% YTD: What's Driving the Rally?
by Zacks Equity Research
Colfax (CFX) is likely to continue benefiting from acquisitions, productivity actions and product developments. However, a highly leveraged balance sheet remains a concern.
Colfax (CFX) Q3 Earnings Beat Estimates, Up Y/Y on Buyouts
by Zacks Equity Research
Colfax's (CFX) third-quarter 2019 results benefit from improved sales performance, with buyouts playing a significant role.
Colfax (CFX) Surpasses Q3 Earnings Estimates
by Zacks Equity Research
Colfax (CFX) delivered earnings and revenue surprises of 8.70% and -0.10%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Colfax (CFX) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Colfax (CFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why it is Worth Holding on to Colfax (CFX) Stock Now
by Zacks Equity Research
Colfax (CFX) is likely to gain from opportunities in fabrication technology and orthopedic solutions businesses, buyouts, and emerging market exposure. High costs, huge debts and forex woes are dragging.
IDEX's Diversified Business and Buyouts Aid Despite Forex Woes
by Zacks Equity Research
IDEX (IEX) gains from a diversified business structure, solid product offerings, acquired assets and shareholder-friendly policies. Geopolitical uncertainties and forex woes are headwinds.
Colfax Completes Divestment of Air & Gas Handling Business
by Zacks Equity Research
Colfax's (CFX) Air & Gas Handling divestment will help it pay down debts as well as concentrate on core and profitable businesses.
Reasons Why Investors Should Avoid Applied Industrial Now
by Zacks Equity Research
Applied Industrial (AIT) suffers from forex-related woes, high debts, rising costs and uncertainties in the broader industrial cycle.
Cintas (CTAS) to Post Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Cintas' (CTAS) first-quarter fiscal 2020 earnings to gain from solid product portfolio, enterprise resource planning system and acquired assets. Lower working days and high taxes are concerning.
Apogee (APOG) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Solid bidding and order activities, robust backlog and favorable North America commercial construction market likely to aid Apogee's (APOG) fiscal Q2 performance.
Is Colfax Corporation (CFX) a Great Pick for Value Investors?
by Zacks Equity Research
Is Colfax Corporation (CFX) a great pick from the value investor's perspective right now? Read on to know more.
Colfax (CFX) Up 0.4% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Colfax (CFX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Atkore (ATKR) Rallies 46% YTD: What's Driving the Stock?
by Zacks Equity Research
Atkore (ATKR) benefits from volume growth in electrical categories, product launches and acquired assets. Its stock surges year to date, outperforming industry, sector and S&P 500.
Colfax to Gain from Strong End Markets & Buyouts Amid Risks
by Zacks Equity Research
Colfax (CFX) is likely to benefit from its focus on strengthening segmental businesses and productivity actions, and gains from acquired assets. However, rising cost of sales is a concern.
Colfax (CFX) Q2 Earnings Top Estimates, Sales Gain on Buyouts
by Zacks Equity Research
Colfax's (CFX) second-quarter 2019 results benefit from improvement in core sales and acquired assets. It provides projections, after adjusting for the pending divestment of the Air and Gas Handling segment.
Colfax (CFX) Beats Q2 Earnings Estimates
by Zacks Equity Research
Colfax (CFX) delivered earnings and revenue surprises of 6.67% and -27.15%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Here's Why You Should Avoid Betting on Colfax (CFX) Stock Now
by Zacks Equity Research
Colfax (CFX) might suffer from high costs and operating expenses, huge debt levels, and unfavorable movements in foreign currencies.
Why Is Colfax (CFX) Down 0.2% Since Last Earnings Report?
by Zacks Equity Research
Colfax (CFX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Colfax (CFX) to Divest Air and Gas Handling Business to KPS
by Zacks Equity Research
The divestiture of Air and Gas Handling business will enable Colfax (CFX) to reach its leverage target and raise profitability ratio.
Colfax (CFX) Poised to Gain From Buyouts, Suffers From Debts
by Zacks Equity Research
Colfax's (CFX) acquisition of DJO Global marks its entry into the orthopedic solutions industry. High debts and forex woes remain concerning.
Colfax (CFX) Q1 Earnings Top Estimates, Gain From Buyouts
by Zacks Equity Research
Colfax's (CFX) first-quarter 2019 results benefit from gains from acquired assets, especially DJO Global as well as improvement in existing businesses and margins.
Colfax (CFX) Q1 Earnings Surpass Estimates
by Zacks Equity Research
Colfax (CFX) delivered earnings and revenue surprises of 8.16% and -2.34%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Emerson (EMR) to Report Q2 Earnings: Will it Disappoint?
by Zacks Equity Research
Emerson's (EMR) second-quarter fiscal 2019 results are likely to be hurt by rising operating costs and expenses, and unfavorable movement in foreign currencies.